Industries > Pharma > Global Angioplasty Balloons Market 2019-2029

Global Angioplasty Balloons Market 2019-2029

Revenue Prospects by Product Type (Normal, Drug-Eluting, Cutting & Scoring Balloons), Application (Coronary Artery Disease, Peripheral Artery Diseases) and Geography

PUBLISHED: 29 April 2019
PAGES: 131
PRODUCT CODE: PHA0387
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0387 Categories: , Tag:

Angioplasty Balloons – our new study reveals trends, R&D progress, and predicted revenues
Where is the Angioplasty Balloons market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2029, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 131-page report provides 94 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing market. See how to exploit the opportunities with this report, now.

Forecasts to 2029 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2029, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 4 Product Types and 2 Applications.

Angioplasty Balloons Market Forecasts to 2029, By Product Type
• Normal Balloons
• Drug-Eluting Balloons
• Cutting Balloons
• Scoring Balloons

Angioplasty Balloons Market Forecasts to 2029, By Application
• Coronary Artery Disease
• Peripheral Artery Diseases

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets:
• The US
• Germany
• France
• The UK
• Italy
• Spain
• Japan
• China
• India
• Brazil
• Russia
• Mexico
• RoW

Global Angioplasty Balloons Market 2019-2029

The report also includes profiles and forecasts for some of the leading companies in the Angioplasty Balloon market, with a focus on the Vascular segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2029. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth
Overall world revenue for Angioplasty Balloons will surpass $2.6bn in 2017, our work calculates. We predict strong revenue growth through to 2029. Increasing incidence of cardiovascular and peripheral arterial diseases, rising healthcare expenditure in emerging countries and the increasing geriatric population are likely to drive the market over the forecast period.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Angioplasty Balloon Market report helps you
In summary, our 131-page report provides you with the following knowledge:
Revenue forecasts to 2029 for the world Angioplasty Balloon market and 2 different segmentations, with 4 product types and 2 applications – discover the industry’s prospects, finding the most lucrative places for investments and revenues
Revenue forecasts to 2029 for 12 of the leading national markets – US, Germany, UK, France, Italy, Spain, Japan, Brazil, China, India, Russia, Mexico and the Rest of the World.
Discussion of what stimulates and restrains companies and the market
Prospects for established firms and those seeking to enter the market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the Angioplasty Balloon market and leading companies. You find data, trends and predictions.

Get our report today Global Angioplasty Balloons Market 2019-2029: Revenue Prospects by Product Type (Normal, Drug-Eluting, Cutting & Scoring Balloons), Application (Coronary Artery Disease, Peripheral Artery Diseases) and Geography. Avoid missing out – get our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Angioplasty Balloons Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Angioplasty Balloons Market 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category